PCH2E is caused by variants of mutant VPS53. The clinical manifestations of the disease include developmental delay, spasticity features, seizure, microcephaly, optic atrophy and nystagmus, and facial dysmorphism [50, 51]. This evidence concerns the gene VPS53 and hereditary optic atrophy.